Real Regulatory to take part in the Drug Repurposing for Rare Diseases Conference
Will you be at the Drug Repurposing for Rare Diseases Conference in London?
Findacure’s Drug Repurposing for Rare Diseases Conference, now in its seventh year, showcases excellence in the development of repurposed drugs for rare disease patients.
Held annually in recognition of Rare Disease Day, the conference shares ground-breaking drug repurposing projects, highlights the potential for patient group-led innovation, and emphasises repurposing as a valid business model for orphan drug development.
Chat with our team about how we can help you to navigate liaison with the European agencies, support you to build an optimum regulatory strategy and implement that strategy on your behalf right through to a successful MAA.
Contact us today to arrange a meeting at a time that suits your schedule. We look forward to seeing you at the conference!
Attendees: Leslie Dowling
Leslie joined the company in April 2017 and has worked in EU regulatory affairs since 1997 mainly in human medicinal products, including advanced therapies and clinical regulatory support, both within small/medium pharma and as consultant/CRO with small to large pharma clients.
Leslie’s current role is as Managing Consultant in charge of the UK office, managing a growing team of consultants whilst providing expert consultancy to client projects.
Leslie is a current holder of the Regulatory Affairs Certification [RAC(EU)] credential and a Fellow of The Organisation for Professionals in Regulatory Affairs (TOPRA). She has experience in a variety of therapeutic areas including gene therapy, oncology, neurology and respiratory.
